|
immatics appoints Dr Rainer Kramer as Chief Business Officer |
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr. |
12.04.2012 |
|
Insilico on the fast track: Supercomputer breaks into new high performance dimensions |
“Hermit“, the new supercomputer, was put into action in HLRS, the High Performance Computing Center in Stuttgart, in February 2012. The event was crowned by the presence of Prof.Dr. |
03.04.2012 |
|
Seeing movement: Why the world in our head stays still when we move our eyes |
When observing a fly buzzing around the room and following it around with the eyes, we ought to have the impression that it is not the fly, but rather the space that lies behind it that is moving. |
28.03.2012 |
|
Protagen and NMI announce Co-Development of Multiplex Assays |
"Protagen has a unique expertise in high-throughput expression of human proteins and the conduct of clinical validation studies for serum biomarkers. |
19.03.2012 |
|
Implant to replace defective venous valve |
It’s one of the most commonly occurring medical conditions – chronic venous in-sufficiency (CVI). |
06.03.2012 |
|
NewModeling Platform for Industrial Bioproduction |
A model is only as good as the databasebehind it but there is more to the picture than just the quality and quantity of the datastored there. |
30.01.2012 |
|
immatics presents positive Phase II results with its therapeutic cancer vaccine IMA910 in patients with advanced colorectal cancer at the ASCO Gastrointestinal Cancers Symposium |
Tuebingen, 24 January, 2012 - immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced positive r |
26.01.2012 |
|
CureVac, Sanofi Pasteur and In-Cell-Art collaborate on a $33.1 million project co-funded by the U.S. Defense Advanced Research Projects Agency |
CureVac GmbH today announced the signing of several agreements with Sanofi Pasteur S.A., the vaccines division of Sanofi(EURONEXT: SAN and NYSE: SNY). |
15.11.2011 |
|
Genomnia srl has signed an agreement with Germany's CeGaT to distribute in Italy Sequencing-Based Dx Tests on SOLiD for a range of Diseases |
Genomnia is a Start-up SME founded in October 2008, as a spin off of ab medica spa, with the aim of offering deep sequencing and bioinformatic services and collaborations with private and public in |
07.11.2011 |
|
High-tech spider for hazardous missions |
|
03.11.2011 |